Download The Whitepaper
Expert Insights with Cancer Experts, Dr. Kiyoshi Hashigami and Dr. Morihiro Watanabe
Expert Insights with Cancer Experts, Dr. Kiyoshi Hashigami and Dr. Morihiro Watanabe
Oncology Clinical Development in Asia Pacific
In the newly released whitepaper, we examine the key insights of two distinguished cancer researchers, Dr. Kiyoshi Hashigami and Dr. Morihiro Watanabe, who provide a caliber of experience and expertise to the forefront of oncology clinical development.
Through their perspectives, we explore the driving forces behind the unprecedented growth in oncology trials in Asia Pacific, the unique challenges and opportunities presented by the region’s diverse landscape, and the transformative impact of emerging trends such as precision medicine, immunotherapy, and novel therapeutic modalities.
Hematology & Oncology
An integrated Approach
With our proven full-service outsourcing model, Medpace delivers high-quality results. In the competitive field of hematology and oncology, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.
- Global, in-house medical experts across a wide range of therapeutic areas, including hematology and oncology, and global regions, including Asia Pacific, Europe, and the US—demonstrated by 250+ hematology and oncology trials
- Comprehensive regulatory affairs and operational experts who work collaboratively with our medical team
- Expedited start-up and recruitment, including long-term site relationships and preferred CRO status with key Phase I hematology and oncology centers
- Integrated tumor imaging and central laboratory services, ensuring seamless logistics, review, and testing
